We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics

News   Jul 27, 2009

 
miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics
 
 
Advertisement
 

RELATED ARTICLES

Dutch Vico Therapeutics Appoints Rupert Sandbrink and Anders Hinsby as CMO and Independent Director

News

Vico Therapeutics, a biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, announced the appointment of Rupert Sandbrink, M.D., Ph.D., as the company’s chief medical officer and Anders Hinsby, Ph.D., as independent Director on the 1st October.

READ MORE

Protein Influences Regeneration of Vascular Cells

News

Researchers have discovered how the communication between individual cells can be influenced with the help of a specific protein, which could have implications for the treatment of heart diseases.

READ MORE

Radiation Sickness Could Be Detected in a Single Drop of Blood

News

A new proof-of-concept study reports evidence that a new testing method has the potential to rapidly identify radiation sickness based on biomarkers measured through a single drop of blood.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE